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Abstract:  Problem statement: After HIV infection, TB is the most common cause of mortality due 
to a single infectious agent. Until 1985, tuberculosis cases in the world were decreasing every year, but 
then with the prevalence of HIV infection, TB cases are increasing every year. Obviously, with this 
prevalence of tuberculosis, the best way to control it is to track the patient and identify the people with 
latent TB and treat them. One third of the world population is infected with latent tuberculosis micro 
bacterium and tuberculosis causes two million deaths a year. Identification of people with latent TB 
infection  is  the  primary  aim  to  eradicate  TB  in  the  community. The  method  to  measure  gamma 
interferon in the blood called QuantiFERON®-TB Test is a promising diagnostic test for diagnosing 
latent  TB  infection  and  is  more  beneficent  than  compared  to  PPD. The  aim  of  this  study  is  to 
compare IFN-δ  test  and  PPD test  in  diagnosis  of  patients  with  latent TB.  Approach:  In  a  cross-
sectional descriptive-analytic study on 76 patients referred to the clinic or infectious diseases ward of 
Imam Reza or Sina hospitals or Tabriz University of Medical Sciences during 2007 and 2008, the 
patients  whose CXR had fibrotic images or calcification  compatible  with latent TB infection  were 
included in the study and the correlations between IFN-δ and PPD tests was evaluated. Results: Mean 
age  of  the  patients  in  this  study  was  64.96±4.54  years  with  minimum  43  and  maximum  81  of 
age. About 33.3% of people under study had a positive PPD test and 4% of the patients had a positive 
IFN-δ 
 
and  the  correlation  coefficient  between IFN-δ  test 
 
and PPD  test was  estimated  at  0.376 
(p<01/0). Age  and  gender  had  no  effect  on  positivity  of  the  results  of  PPD test  and  IFN-
δ tests. Conclusion: Capability of IFN-δ test in diagnosis of latent tuberculosis infection is comparable 
to that of PPD test; however, the correlation coefficient between the two tests was low and also, unlike 
other studies, gender and age had no effect on positivity or negativity of PPD and IFN-δ tests.  
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INTRODUCTION 
 
Introduction  and  importance  of  the  subject:  After 
HIV  infection, TB  is  the  most  common  cause  of 
mortality due to a single infectious agent. Until 1985, 
tuberculosis cases in the world were decreasing every 
year, but then with the prevalence of HIV infection, TB 
cases  are  increasing  every  year  (Mandell  et  al., 
2005). Obviously, with this prevalence of tuberculosis, 
the  best  way  to  control  it  is  to  track  the  patient  and 
identify  the  people  with  latent  TB  and  treat  them 
(Mandell  et  al.,  2005). One  third  of  the  world 
population  is  infected  with  latent  tuberculosis  micro 
bacterium and tuberculosis causes two million deaths a 
year (Mandell et al., 2005). 
  In some people, the relative risk of transformation 
of latent TB to active TB is very high; like people with 
one of the following conditions: diabetes, chronic renal 
failure, Gastrectomy, limb transplanting, head and neck 
carcinoma,  pregnancy,  receiving  corticosteroids, 
malnutrition  and  HIV infected people (Mandell  et  al., 
2005).  All   HIV-positive   people  with latent TB, if 
not    treated,    will  eventually  develop  active  TB 
(Mandell et al., 2005). 
  Regarding  these  facts,  identification  of  people 
contaminated  with  tuberculosis  Mycobacterium  is 
necessary for TB control (Mandell et al., 2005). Since 
over than 30 years ago, treatment of latent TB infection 
to prevent active disease has been an essential part of 
TB    control    programs    in  developing  countries 
(Mandell et al., 2005). Currently Tuberculin skin test, 
known as PPD test, is the Choice method for diagnosis 
of latent TB in the world. Am. J. Infect. Dis., 6 (2): 50-53, 2010 
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  During recent years, more attention has been drawn 
to a new test called Quantiferon-TB Test in which the 
level  of IFN-δ  in  blood  is  measured.  This  test  is 
currently under study over the world and in some areas 
the  correlations  between IFN-δ  and PPD test was  high 
and in some other regions this correlation is low. The 
aim of this study is to compare IFN-δ and PPD test in 
diagnosis of patients with latent TB. 
 
MATERIALS AND METHODS  
 
  In  a  cross-sectional  descriptive-analytic  study  on 
76 patients referred to the clinic or infectious diseases 
ward  of  Imam  Reza  or  Sina  hospitals  or  Tabriz 
University of Medical Sciences during 2007 and 2008, 
the  patients  whose CXR had  fibrotic  images  or 
calcification compatible with latent TB infection were 
included in the study and the correlation between IFN-δ 
and PPD tests was evaluated.  
  Sample volume to be studied was estimated at 76 
people based on the following formula: 
 
 
2
a B 1 2 N [(Z Z ) (C C )] 3 = + ¸ - +  
 
Inclusion  criteria:  Patients  in  Infectious  diseases 
wards  of  these  two  medical  centers  and  the  patients 
referred  to  clinics  of  infectious  diseases  who  had 
fibrotic images and calcification compatible with latent 
TB in their CXR were included in this study (CXR was 
performed only on patients with graphic indication). 
 
Exclusion criteria: 
 
·  People  with  positive  Wright and Coombs 
Wright test  results  (gamma  interferon  level  at 
Brucellosis  rises,  so  brucellosis  tests  were 
performed on all  subjects before inclusion in the 
study  and  the  cases  with  positive  results  were 
excluded) 
·  People  not  consent  for  PPD test and  blood 
sampling for IFN-δ 
·  People with a history of TB treatment 
·  Patients with Ralper clinical symptoms were also 
excluded  
 
After selecting patients, the PPD test was performed 
with  the  following  conditions:  To  perform  this  test, 
firstly,  area  of  the  left  anterior  forearm  was  washed 
with alcohol and then cleaned  with distilled  water to 
clear the skin of alcohol because remaining alcohol on 
the  skin  will  lead  to  false  negative  test  result  due  to 
denaturation of proteins in PPD solution. After drying 
the skin, 5 units of 0.1 mL PPD solution was injected 
intraperitoneally and the test results were read after 48-
72  h. To  read  the PPD test  result,  the  indurations 
perpendicular to the injection line should be measured 
and  notes  in  terms  of  millimeters. Then  1  cc  of 
complete blood was taken from the subjects and after 
the blood clots inside the test tube, it was centrifuged 
for 5  min until serum  was separated, then the  serum 
over the clot was drawn into plastic tubes and freeze in 
-70°C  temperature. After  completion  of  this  part  and 
preparing 76 samples, the serums  were transferred to 
the  laboratory  of  Pharmaceutical  Applied  Researches 
Center and the amount of their IFN-δ were measured 
by Elisa  method. Based  on  previous  studies, positive 
Cutoff point of this test was assumed at 10pgr mL
-1; so, 
the samples with 10 pgr mL
-1≤IFN-δ were considered 
positive  and  the  samples  with  IFN-δ  less  than  this 
amount were considered negative (Brock et al., 2004). 
  Coombs  Wright  and  Wight tests were  also 
performed on all the patients under study and patients 
with  positive  test  result  were  excluded  from  the 
study. Written  consent  of  the  patients  was  obtained 
for PPD test and taking blood sample for IFN-δ test and 
non-consent cases were excluded. 
  Data  obtained  through  SPSS  statistical 
software (Ver.  13) and  Pearson Correlation  statistical 
tests were statistically analyzed. In this study, p<0.05 
has been considered as the significant level. 
 
RESULTS 
 
  Mean age of patients in this study was 64.96±4.54 
in the range of 43-81 years. About 50 cases (66.6%) of 
the  patients  under  study  were  male  and  26  cases 
(33.4%) were female. All of the cases had the history 
of BCG vaccination  during  childhood.  PPD test 
result in 25 patients, 15 males (60%) and 10 females 
(40%), was positive (PPD≥10 mm). Average age of the 
patients with positive PPD was 62.54±2.66 years. IFN-
δ test was positive only in 3 patients (2 males and 1 
female) whose PPD test result were also positive and 
over  15mm.  Mean  age  of  the  patients  with  positive 
IFN-δ  test  result  was  61.84±3.43  years.  PPD test 
results in patients were shown in Fig. 1. 
  In  order  to  evaluate  the  correlation  coefficient 
between  IFN-δ  and  PPD tests,  Pearson  correlation 
test was  applied.  The  correlation  coefficient  between 
IFN-δ  and PPD tests  on  the  cases  under  study  was 
0.376 and significant (p<0.01).  
  Positivity rate of PPD test (p = 0.509) and IFN-δ 
test (p = 0.413)
 
 had no significant relationship with 
the  age  of  the  patients.   Positivity    rate    of    PPD  
test (p  =  0.131) and IFN-δ  test  (p  =  0.338)
 
  had  no 
significant relationship with the gender of the patients. Am. J. Infect. Dis., 6 (2): 50-53, 2010 
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Fig. 1: PPD test results in patients under study 
 
DISCUSSION 
 
  Due to many cases of false positive and negative 
PPD  test results, this  test  cannot  be  used  as 
the gold standard  and  with  the  re-prevalence  of  TB 
infection along with the growth of HIV infection, lack 
of  such  tests  for  diagnosing  latent  TB  infection  are 
more obvious; since the best way to control TB in the 
community is to identify and treat people  with latent 
TB. PPD test  is  a  simple  and  inexpensive  test  with 
medium  to  high  sensitivity,  which  depends  on 
population  screening,  but  its  specificity  is    low 
(Huebner et al., 1993). Many studies indicate a positive 
relationship  between   positive   PPD test and the risk 
of  prospective  active  TB  (Huebner  et al., 1993; 
Ewer  et al., 2003; Mazurek et al., 2001). And several 
studies have shown that treatment of latent tuberculosis 
diagnosed by PPD test reduces active TB risk 60-90% 
(Brock et al., 2004). 
  But  it  needs  a  skilled  tester,  the 
booster phenomenon  occurs  and  BCG vaccine and 
infection  by  non-TB  Mycobacterium  cause  false 
positive test result. 
 
IFN-δ  test:  Have higher specificity  than  PPD test 
and no  cross-reactivity  with BCG vaccine or  infection 
with other non-tuberculosis mycobacterium (Ewer et al., 
2003; Brock et al., 2004; Mazurek and Villarino, 2003; 
Mori et al., 2004). It is fast operative and individual-
independent  (Mazurek  et  al.,  2001; Lalvani, 2003; 
Pai et al., 2004; Chadha, 2003; Chadha  et al., 2005; 
Alonso-Echanove  et  al.,  2001).  However, IFN-δ 
method is not assessed carefully enough and especially 
in  children  and  immunosuppressive  people  and  in 
countries  where  TB  is  endemic,  it  has  not  been  yet 
accurately  evaluated  (Pai  et  al.,  2004). In  poor 
countries, PPD test is still widely in use as a valuable 
test. In India, PPD test has significant use for diagnosis 
of  latent  tuberculosis  infection  in  children  (Chadha, 
2001).  
  On  the  other  hand,  as  seen  in  epidemiologic 
studies, application of tests such as IFN-δ test on high 
risk people who must be tested annually would be more 
difficult  (Chadha,  2001;  2003;  Chadha  et  al., 
2005). Many  studies  have  suggested  that  the positive 
PPD test is  associated  with  the  risk  of  prospective 
active TB (Chadha, 2001; 2003; Brock et al., 2004). 
  To prove the relationship between positive IFN-δ 
test  and  the  risk  of  prospective  active  TB,  long-term 
cohort studies are needed. In such situation, IFN-δ test 
can be a  good  alternative  for PPD test. In  many 
studies, PPD test and IFN-δ  test have  been  compared 
(Ewer et al., 2003; Brock et al., 2004; Mazurek et al., 
2001; Pai et al., 2004) and in many of these studies the 
correlation coefficient between the two tests is high. In 
some  studies,  but  the  correlation  coefficient  between 
the two tests was low (Brock et al., 2004). In a study 
conducted  in  Ethiopia,  the  correlation  coefficient 
between the two tests has been very low, while it has 
been  higher in  the  study  carried  out  in  America 
(K>0.75) (Mandell et al., 2005). 
  In our study, the correlation coefficient between the 
two tests was positive and significant but lower than that 
in other studies (K<0.4) and IFN-δ 
 
test was positive only 
on  three  cases,  but  the  notable  fact  in  this  study  is 
that IFN-δ test was positive on cases where PPD test was 
also positive with a high and significant value. This may 
imply that if IFN-δ test is positive on a person, he can be 
said with certainty to be infected with latent TB; because 
in this study, in cases with Positive IFN-δ test, 15 mm ≤ 
PPD,  that  this  PPD size  in  all  individuals  with  any 
underlying  disease  and  in  any  population,  has  the 
treatment indication of tuberculosis; therefore, if this fact 
proven  in  other  studies,  it  can  be  concluded  that 
wherever IFN-δ  test 
 
is  positive  (unlike  different 
PPD sizes  which should  be interpreted  based  on  age, 
place of living and underlying disease of the individual 
and  determine  the  treatment  indication)  person  will 
unconditionally have latent TB treatment indication. 
  Of course, PPD test may also be negative on TB 
infection,  but  2  weeks  after  starting  anti-TB 
treatment, PPD test  will  be positive (Brock  et  al., 
2004). But IFN-δ test is negative up to one year after 
starting  TB  treatment (Mori  et  al.,  2004;  Alonso-
Echanove et al., 2001). 
  Like  our  study,  several  studies  have  been 
conducted on this case around the world and the same 
results  are  observed  in  various  studies  that 
contradictory results can be seen in this case too. Even 
though  the  FDA test  is approved,  but  due  to  these 
different results, researchers recently believe that some 
other  new  tests  should  replace IFN-δ 
 
and PPD tests. 
One  of  the  new  tests  under  much  attention  in  recent 
years is IL-4 test (Brock et al., 2004; Mori et al., 2004). 
  IL-4 test  is  based  on  measuring  the  amount  of 
interleukin-4  in  the  blood.  This  test  is  currently  being Am. J. Infect. Dis., 6 (2): 50-53, 2010 
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probed and few surveys have been conducted on it, but 
based  on  these  few  studies,  it  has  shown  high  test 
sensitivity and fewer false negative cases and it can be 
used for tracking after treatment of pulmonary tuberculosis 
(Ewer et al., 2003; Alonso-Echanove et al., 2001). 
  However, like the IFN-δ test, this test should also be 
evaluated in countries with endemic TB and investigated 
on people with latent TB and pulmonary TB. 
  In a study carried out recently in India, IFN-δ and IL-
4 tests  were  used  simultaneously  to  identify  latent 
tuberculosis that has shown better results rather than using 
each test alone. It is expected that such researches would 
be performed in our country in the future. 
  Considering the fact that Iran is among countries 
with endemic TB and the increase of IVDU and HIV-
positive people and  re-prevalence  of  TB,  many 
researches, including gamma interferon and interleukin-
4 should be conducted in our country for the diagnosis 
of latent TB; so that these tests could be discussed on. 
  In this study, there was no relationship between 
age  and  sex  and  positivity  of PPD  and IFN-δ  tests; 
While  age  was  considered  as  a  risk  factor  in  some 
studies  and  positive PPD and IFN-δ  cases  has  been 
increasing  with increase of age (Ewer  et al., 2003; 
Alonso-Echanove et al., 2001). 
 
CONCLUSION 
 
  Correlation  coefficient  between  the PPD test and 
gamma interferon was r = 0.376. Age and sex had no 
effect on positivity of PPD and IFN-δ tests. IFN-δ test 
was positive wherever PPD size ≥15 mm which could 
indicate latent tuberculosis infection in any individual 
and any population. 
 
Suggestions: It seems that yet some other studies are 
needed for replacing the IFN-δ test instead of PPD test; 
especially, studies should also be done on children and 
immunosuppressive people. Moreover, in order to state 
the association of positive IFN-δ test with prospective 
active  TB  risk,  long-term  cohort  studies  should  be 
performed. However, what was expressed in this study 
like other studies was that PPD test is currently the only 
available applicable test to diagnose latent TB infection 
and replacement of IFN-δ test requires further studies; 
because, Iran is among endemic countries in terms of 
TB  and,  as  observed,  the  correlation  coefficient 
between the two tests was low in such country. 
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